Insmed
INSM
#542
Rank
HK$338.56 B
Marketcap
HK$1,587
Share price
-0.51%
Change (1 day)
170.81%
Change (1 year)

Insmed (INSM) - Total debt

Total debt on the balance sheet as of September 2025 : HK$4.48 Billion

According to Insmed's latest financial reports the company's total debt is HK$4.48 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Insmed - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$8.91 B-5.15%
2023-12-31HK$9.40 B2.18%
2022-12-31HK$9.20 B92.76%
2021-12-31HK$4.77 B52.12%
2020-12-31HK$3.13 B1.5%
2019-12-31HK$3.09 B24.74%
2018-12-31HK$2.47 B471%
2017-12-31HK$0.43 B2.18%
2016-12-31HK$0.42 B118.05%
2015-12-31HK$0.19 B1.07%
2014-12-31HK$0.19 B26.3%
2013-12-31HK$0.15 B1.57%
2012-12-31HK$0.15 B6810.29%
2011-12-31HK$2.17 M70.4%
2010-12-31HK$1.27 M-20.86%
2009-12-31HK$1.61 M-90.07%
2008-12-31HK$16.24 M-38.26%
2007-12-31HK$26.3 M7.01%
2006-12-31HK$24.58 M-50.74%
2005-12-31HK$49.9 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sarepta Therapeutics
SRPT
HK$9.72 B 116.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$249.18 B 5,456.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
HK$194.08 B 4,227.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
HK$5.29 B 18.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$2.62 B-41.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$14.27 B 218.39%๐Ÿ‡บ๐Ÿ‡ธ USA